C

CyGenica

5 employees

CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs and antibiotics.

Basic info

Industry

research services

Sectors

Biotechnology
Lab Reagents
Fluorescent dyes
Manufactoring
Pharmaceutical Industry
Agriculture
Drug delivery system
Cancer

Date founded

2017

Funding rounds raised

Total raised

$1.4M

from 1 investors over 1 rounds

C

CyGenica raised $1.4M on June 8, 2021

Investors: SOSV - The Accelerator VC

FAQ